Disposition of 372 shares by Erin Burkhart of Biomarin Pharmaceutical at 83.87 subject to Rule 16b-3
| VMCRX Fund | USD 6.08 0.06 1.00% |
Slightly above 51% of Voya Midcap's investors are presently thinking to get in. The analysis of overall sentiment of trading Voya Midcap Opportunities mutual fund suggests that some investors are interested at this time. Voya Midcap's investing sentiment can be driven by a variety of factors including economic data, Voya Midcap's earnings reports, geopolitical events, and overall market trends.
Voya |
Filed transaction by Biomarin Pharmaceutical Officer: Gvp, Chief Accounting Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at finance.yahoo.com
 |
Voya Midcap Fundamental Analysis
We analyze Voya Midcap's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Voya Midcap using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Voya Midcap based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Voya Midcap is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Voya Midcap Opportunities Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Voya Midcap mutual fund to make a market-neutral strategy. Peer analysis of Voya Midcap could also be used in its relative valuation, which is a method of valuing Voya Midcap by comparing valuation metrics with similar companies.
Peers
Voya Midcap Related Equities
| IMCVX | Voya Multi | 0.74 | ||||
| ILUAX | Voya Bond | 0.11 | ||||
| ILMBX | Voya Limited | 0.10 | ||||
| IMCDX | Voya Emerging | 0.00 | ||||
| ILBPX | Voya Limited | 0.11 | ||||
| IMBAX | Voya Limited | 0.11 | ||||
| ILBAX | Voya Bond | 0.33 | ||||
| ILABX | Voya Bond | 0.34 |
Other Information on Investing in Voya Mutual Fund
Voya Midcap financial ratios help investors to determine whether Voya Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Voya with respect to the benefits of owning Voya Midcap security.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |